Literature DB >> 24327079

The neutrophil-lymphocyte ratio is not enough to describe inflammatory condition.

Sevket Balta1, Cengiz Ozturk, Ertugrul Kurtoglu.   

Abstract

Mesh:

Substances:

Year:  2013        PMID: 24327079     DOI: 10.1007/s00405-013-2847-8

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


× No keyword cloud information.
  11 in total

1.  Neutrophil-lymphocyte ratio as a new predictive and prognostic factor at the hearing loss of diabetic patients.

Authors:  Sahin Ulu; Abdulkadir Bucak; M Sena Ulu; Ahmet Ahsen; Abidin Duran; Fatih Yucedag; Abdullah Aycicek
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-10       Impact factor: 2.503

2.  Increased levels of mean platelet volume: a possible relationship with idiopathic sudden hearing loss.

Authors:  Sahin Ulu; M Sena Ulu; Ahmet Ahsen; Fatih Yucedag; Abdullah Aycicek; Sefa Celik
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-01-23       Impact factor: 2.503

3.  Higher neutrophil to lymhocyte ratio in patients with metabolic syndrome.

Authors:  Sevket Balta; Mustafa Cakar; Sait Demirkol; Zekeriya Arslan; Muharrem Akhan
Journal:  Clin Appl Thromb Hemost       Date:  2013-01-23       Impact factor: 2.389

4.  Other inflammatory markers ought to be kept in mind when assessing the mean platelet volume in clinical practice.

Authors:  Sevket Balta; Sait Demirkol; Uzeyir Yildizoglu; Zekeriya Arslan; Murat Unlu; Turgay Celik
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-04-25       Impact factor: 2.503

5.  Other inflammatory markers should not be forgetten when assessing the neutrophil-to-lymphocyte ratio.

Authors:  Sevket Balta; Sait Demirkol; Mustafa Cakar; Zekeriya Arslan; Murat Unlu; Turgay Celik
Journal:  Clin Appl Thromb Hemost       Date:  2013-04-23       Impact factor: 2.389

6.  Elevated serum levels of endocan in patients with psoriasis vulgaris: correlations with cardiovascular risk and activity of disease.

Authors:  I Balta; S Balta; S Demirkol; D P Mikhailidis; T Celik; M Akhan; O Kurt; Y G Kurt; I Aydin; S Kilic
Journal:  Br J Dermatol       Date:  2013-11       Impact factor: 9.302

7.  The comparative effects of valsartan and amlodipine on vWf levels and N/L ratio in patients with newly diagnosed hypertension.

Authors:  Murat Karaman; Sevket Balta; A Y Seyit Ahmet; Mustafa Cakar; Ilkin Naharci; Sait Demirkol; Turgay Celik; Zekeriya Arslan; Omer Kurt; Necmettin Kocak; Hakan Sarlak; Seref Demirbas; Fatih Bulucu; Ergun Bozoglu
Journal:  Clin Exp Hypertens       Date:  2013-01-04       Impact factor: 1.749

8.  Neutrophil to lymphocyte ratio as a measure of systemic inflammation in psoriasis.

Authors:  Bilge Bulbul Sen; Emine Nur Rifaioglu; Ozlem Ekiz; Mehmet Ugur Inan; Tugba Sen; Nihat Sen
Journal:  Cutan Ocul Toxicol       Date:  2013-10-22       Impact factor: 1.820

9.  Neutrophils/lymphocytes ratio in patients with cardiac syndrome X and its association with carotid intima-media thickness.

Authors:  Sait Demirkol; Sevket Balta; Murat Unlu; Zekeriya Arslan; Mustafa Cakar; Ugur Kucuk; Turgay Celik; Erol Arslan; Turker Turker; Atila Iyisoy; Mehmet Yokusoglu
Journal:  Clin Appl Thromb Hemost       Date:  2012-11-26       Impact factor: 2.389

10.  Neutrophil to lymphocyte ratio may be predict of mortality in all conditions.

Authors:  S Balta; S Demirkol; M Unlu; Z Arslan; T Celik
Journal:  Br J Cancer       Date:  2013-10-01       Impact factor: 7.640

View more
  3 in total

1.  Neutrophil to lymphocyte ratio in allergic rhinitis.

Authors:  Viroj Wiwanitkit
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-01-13       Impact factor: 2.503

2.  Assessment of the relationship between neutrophil-lymphocyte ratio and hearing loss of diabetics.

Authors:  Erdim Sertoglu; Metin Uyanik; Huseyin Kayadibi
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-12-04       Impact factor: 2.503

3.  Commentary to: 'Is neutrophil-lymphocyte ratio associated with the severity of allergic rhinitis in children?' Doi: 10.1007/s00405-015-3819-y.

Authors:  Satvinder Singh Bakshi
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-03-28       Impact factor: 2.503

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.